Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 37 results.
User Information
Export Records
  1. 1.   In-utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns
  2. Lin, Shu-Hong; Wang, Youjin; Hartley, Stephen W.; Karyadi, Danielle M.; Lee, Olivia W.; Zhu, Bin; Zhou,Weiyin; Brown, Derek W.; Beilstein-Wedel, Erin; Hazra, Rohan; Kacanek, Deborah; Chadwick, Ellen G.; Marsit, Carmen J.; Poirier, Miriam C.; Brummel, Sean S.; Chanock, Stephen J.; Engels, Eric A.; Machiela, Mitchell J.
  3. AIDS. 2021, Aug 1; 35(10): 1525-1535.
  1. 2.   Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birth
  2. Wang, Youjin; Brummel, Sean S; Beilstein-Wedel, Erin; Dagnall,Casey; Hazra, Rohan; Kacanek, Deborah; Chadwick, Ellen G; Marsit, Carmen J; Chanock, Stephen J; Savage, Sharon A; Poirier, Miriam C; Machiela, Mitchell J; Engels, Eric A
  3. AIDS (London, England). 2019, NOV 1; 33(13): 2091-2096.
  1. 3.   Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine
  2. Boltz, V. F.; Zheng, Y.; Lockman, S.; Hong, F. Y.; Halvas, E. K.; McIntyre, J.; Currier, J. S.; Chibowa, M. C.; Kanyama, C.; Nair, A.; Owino-Ong'or, W.; Hughes, M.; Coffin, J. M.; Mellors, J. W.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, May; 108(22): 9202-9207.
  1. 4.   Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations
  2. Lengruber, R. B.; Delviks-Frankenberry, K. A.; Nikolenko, G. N.; Baumann, J.; Santos, A. F.; Pathak, V. K.; Soares, M. A.
  3. Journal of Antimicrobial Chemotherapy. 2011, Apr; 66(4): 702-708.
  1. 5.   Progressive Mitochondrial Compromise in Brains and Livers of Primates Exposed In Utero to Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  2. Divi, R. L.; Einem, T. L.; Fletcher, S. L. L.; Shockley, M. E.; Kuo, M. M.; St Claire, M. C.; Cook, A.; Nagashima, K.; Harbaugh, S. W.; Harbaugh, J. W.; Poirier, M. C.
  3. Toxicological Sciences. 2010, Nov; 118(1): 191-201.
  1. 6.   Interferon-alpha Produces Significant Decreases in HIV Load
  2. Tavel, J. A.; Huang, C. Y.; Shen, J.; Metcalf, J. A.; Dewar, R.; Shah, A.; Vasudevachari, M. B.; Follmann, D. A.; Herpin, B.; Davey, R. T.; Polis, M. A.; Kovacs, J.; Masur, H.; Lane, H. C.
  3. Journal of Interferon and Cytokine Research. 2010, Jul; 30(7): 461-464.
  1. 7.   A Novel Molecular Mechanism of Dual Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors
  2. Nikolenko, G. N.; Delviks-Frankenberry, K. A.; Pathak, V. K.
  3. Journal of Virology. 2010, May; 84(10): 5238-5249.
  1. 8.   The Path Well Traveled: Using Mammalian Retroviruses to Guide Research on XMRV
  2. Lee, K.; Jones, K. S.
  3. Molecular Interventions. 2010, Feb; 10(1): 20-24.
  1. 9.   HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision
  2. Delviks-Frankenberry, K. A.; Nikolenko, G. N.; Boyer, P. L.; Hughes, S. H.; Coffin, J. M.; Jere, A.; Pathak, V. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(31): 10943-10948.
  1. 10.   Erythrocebus patas monkey offspring exposed perinatally to NRTIs sustain skeletal muscle mitochondrial compromise at birth and at 1 year of age
  2. Divi, R. L.; Leonard, S. L.; Walker, B. L.; Kuo, M. M.; Shockley, M. E.; St Claire, M. C.; Nagashima, K.; Harbaugh, S. W.; Harbaugh, J. W.; Poirier, M. C.
  3. Toxicological Sciences. 2007, Sep; 99(1): 203-213.
  1. 11.   Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3 '-azido-3 '-dideoxythymidine
  2. Brehm, J. H.; Koontz, D.; Meteer, J. D.; Pathak, V.; Sluis-Cremer, N.; Mellors, J. W.
  3. Journal of Virology. 2007, Aug; 81(15): 7852-7859.
  1. 12.   Mutations in the connection domain of HIV-1 reverse transcriptase increase 3 '-azido-3 '-deoxythymidine resistance
  2. Nikolenko, G. N.; Delviks-Frankenberry, K. A.; Palmer, S.; Maldarelli, F.; Fivash, M. J.; Coffin, J. M.; Pathak, V. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Jan; 104(1): 317-322.
  1. 13.   Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity
  2. Divi, R. L.; Leonard, S. L.; Kuo, M. M.; Nagashima, K.; Thamire, C.; St Claire, M. C.; Wade, N. A.; Walker, V. E.; Poirier, M. C.
  3. Environmental and Molecular Mutagenesis. 2007, Apr-May; 48(3-4): 201-209.
  1. 14.   Effects of the Delta 67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision
  2. Boyer, P. L.; Imamichi, T.; Sarafianos, S. G.; Arnold, E.; Hughes, S. H.
  3. Journal of Virology. 2004, SEP; 78(18): 9987-9997.
  1. 15.   Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir
  2. Divi, R. L.; Walker, V. E.; Wade, N. A.; Nagashima, K.; Seilkopf, S. K.; Adams, M. E.; Nesel, C. J.; O'Neill, J. P.; Abrams, E. J.; Poirier, M. C.
  3. Aids. 2004 18(7): 1013-1021.
  1. 16.   Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine
  2. Gerschenson, M.; Nguyen, V.; Ewings, E. L.; Ceresa, A.; Shaw, J. A.; St Claire, M. C.; Nagashima, K.; Harbaugh, S. W.; Harbaugh, J. W.; Olivero, O. A.; Divi, R. L.; Albert, P. S.; Poirier, M. C.
  3. Aids Research and Human Retroviruses. 2004 20(1): 91-100.
  1. 17.   The Delta 67 complex of mutations enhances the ability of HIV-1 reverse transcriptase to excise zidovudine, stavudine and PMPA from blocked primers
  2. Boyer, P. L.; Imamichi, T.; Sarafianos, S. G.; Arnold, E.; Hughes, S. H.
  3. Antiviral Therapy. 2003, JUN; 8(3): U42, Abstract 30-U42, Abstract 30.
  1. 18.   Retroviral recombination: Review of genetic analyses
  2. Hu, W. S.; Rhodes, T.; Dang, Q.; Pathak, V.
  3. Frontiers in Bioscience. 2003 8: D143-D155.
  1. 19.   Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors
  2. Hill, S. A.; Lloyd, P. A.; McDonald, S.; Wykoff, J.; Derse, D.
  3. Journal of Infectious Diseases. 2003 188(3): 424-427.
  1. 21.   Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis
  2. Bissel, S. J.; Wang, G. J.; Ghosh, M.; Reinhart, T. A.; Capuano, S.; Cole, K. S.; Murphey-Corb, M.; Piatak, M.; Lifson, J. D.; Wiley, C. A.
  3. American Journal of Pathology. 2002 160(3): 927-941.
  1. 22.   Relative replication fitness of a high-level 3 '-azido-3 '- deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr -> Gly) at codon 69
  2. Imamichi, T.; Berg, S. C.; Imamichi, H.; Lopez, J. C.; Metcalf, J. A.; Falloon, J.; Lane, H. C.
  3. Journal of Virology. 2000 74(23): 10958-10964.
  1. 23.   Oxidative DNA damage in fetal tissues after transplacental exposure to 3 '-azido-3 '-deoxythymidine (AZT)
  2. Bialkowska, A.; Bialkowski, K.; Gerschenson, M.; Diwan, B. A.; Jones, A. B.; Olivero, O. A.; Poirier, M. C.; Anderson, L. M.; Kasprzak, S.; Sipowicz, M. A.
  3. Carcinogenesis. 2000 21(5): 1059-1062.
  1. 24.   Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy - A randomized controlled trial
  2. Davey, R. T.; Murphy, R. L.; Graziano, F. M.; Boswell, S. L.; Pavia, A. T.; Cancio, M.; Nadler, J. P.; Chaitt, D. G.; Dewar, R. L.; Sahner, D. K.; Duliege, A. M.; Capra, W. B.; Leong, W. P.; Giedlin, M. A.; Lane, H. C.; Kahn, J. O.
  3. Jama-Journal of the American Medical Association. 2000 284(2): 183-189.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel